| Product Code: ETC9954184 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Sartans Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Sartans Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Sartans Market - Industry Life Cycle |
3.4 United Kingdom (UK) Sartans Market - Porter's Five Forces |
3.5 United Kingdom (UK) Sartans Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United Kingdom (UK) Sartans Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 United Kingdom (UK) Sartans Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) Sartans Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of hypertension and cardiovascular diseases in the UK population |
4.2.2 Increasing awareness about the importance of managing blood pressure and related conditions |
4.2.3 Technological advancements leading to the development of innovative sartans with improved efficacy and fewer side effects |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval of sartan medications |
4.3.2 Competition from alternative treatments such as ACE inhibitors and beta-blockers |
4.3.3 Price pressure due to the presence of generic sartan drugs in the market |
5 United Kingdom (UK) Sartans Market Trends |
6 United Kingdom (UK) Sartans Market, By Types |
6.1 United Kingdom (UK) Sartans Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Sartans Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Sartans Market Revenues & Volume, By Valsartan, 2021- 2031F |
6.1.4 United Kingdom (UK) Sartans Market Revenues & Volume, By Telmisartan, 2021- 2031F |
6.1.5 United Kingdom (UK) Sartans Market Revenues & Volume, By Losartan, 2021- 2031F |
6.1.6 United Kingdom (UK) Sartans Market Revenues & Volume, By Irbesartan, 2021- 2031F |
6.1.7 United Kingdom (UK) Sartans Market Revenues & Volume, By Azilsartan, 2021- 2031F |
6.1.8 United Kingdom (UK) Sartans Market Revenues & Volume, By Olmesartan, 2021- 2031F |
6.2 United Kingdom (UK) Sartans Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Sartans Market Revenues & Volume, By Valsartan, 2021- 2031F |
6.2.3 United Kingdom (UK) Sartans Market Revenues & Volume, By Telmisartan, 2021- 2031F |
6.2.4 United Kingdom (UK) Sartans Market Revenues & Volume, By Losartan, 2021- 2031F |
6.2.5 United Kingdom (UK) Sartans Market Revenues & Volume, By Irbesartan, 2021- 2031F |
6.2.6 United Kingdom (UK) Sartans Market Revenues & Volume, By Azilsartan, 2021- 2031F |
6.2.7 United Kingdom (UK) Sartans Market Revenues & Volume, By Olmesartan, 2021- 2031F |
6.3 United Kingdom (UK) Sartans Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Sartans Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United Kingdom (UK) Sartans Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.3.4 United Kingdom (UK) Sartans Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Sartans Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Sartans Market Export to Major Countries |
7.2 United Kingdom (UK) Sartans Market Imports from Major Countries |
8 United Kingdom (UK) Sartans Market Key Performance Indicators |
8.1 Patient adherence rate to sartan medication prescribed by healthcare providers |
8.2 Number of new product launches and innovations in the sartans market |
8.3 Rate of adoption of sartans in clinical practice as recommended by guidelines |
8.4 Patient satisfaction and feedback regarding the effectiveness and tolerability of sartan medications |
8.5 Level of investment in research and development activities by pharmaceutical companies in the sartans market |
9 United Kingdom (UK) Sartans Market - Opportunity Assessment |
9.1 United Kingdom (UK) Sartans Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United Kingdom (UK) Sartans Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 United Kingdom (UK) Sartans Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) Sartans Market - Competitive Landscape |
10.1 United Kingdom (UK) Sartans Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Sartans Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here